Simbrinza
Drug
Alcon Vision LLC
Total Payments
$491,329
Transactions
10,431
Doctors
4,848
Companies
4
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $24,942 | 1,366 | 546 |
| 2023 | $205,284 | 2,907 | 1,745 |
| 2022 | $126,616 | 6,005 | 3,549 |
| 2021 | $2,318 | 80 | 72 |
| 2017 | $132,169 | 73 | 12 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $231,512 | 10,228 | 47.1% |
| Unspecified | $122,840 | 59 | 25.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $67,223 | 29 | 13.7% |
| Consulting Fee | $55,264 | 46 | 11.2% |
| Travel and Lodging | $14,490 | 69 | 2.9% |
Payments by Type
General
$368,489
10,372 transactions
Research
$122,840
59 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 24-hr Intraocular pressure control with Brinzolamide 1% / Brimonidine 0.2% ophthalmic suspension vs. vehicle. | Alcon Research Ltd | $122,840 | 5 |
Top Doctors Receiving Payments for Simbrinza
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Chapel Hill, NC | $79,023 | 45 |
| , MD | Ophthalmology | Winston-Salem, NC | $29,296 | 16 |
| , M.D | Ophthalmology | Dallas, TX | $8,383 | 14 |
| , MD | Ophthalmology | San Francisco, CA | $8,117 | 15 |
| , MD | Ophthalmology | Petaluma, CA | $7,639 | 13 |
| , MD | Ophthalmology | Dayton, OH | $7,579 | 31 |
| , MD | Glaucoma Specialist | Sugar Land, TX | $7,264 | 10 |
| , M.D | Ophthalmology | New York, NY | $7,250 | 4 |
| , M.D | Ophthalmology | Ypsilanti, MI | $6,674 | 38 |
| , M.D | Ophthalmology | Houston, TX | $6,544 | 9 |
| , MD | Ophthalmology | Coral Gables, FL | $6,122 | 29 |
| , M.D | Ophthalmology | La Jolla, CA | $5,478 | 10 |
| , M.D | Ophthalmology | Chicago, IL | $5,379 | 9 |
| , MD | Ophthalmology | Stanford, CA | $4,703 | 2 |
| , MD | Ophthalmology | Providence, RI | $4,457 | 14 |
| , MD | Ophthalmology | Memphis, TN | $4,441 | 8 |
| , MD | Ophthalmology | Newark, NJ | $4,433 | 6 |
| , MD | Ophthalmology | Atlanta, GA | $4,377 | 14 |
| , MD | Ophthalmology | Norfolk, VA | $4,196 | 3 |
| , MD | Ophthalmology | San Diego, CA | $3,471 | 3 |
| , MD | Ophthalmology | Rancho Cordova, CA | $3,290 | 6 |
| , M.D | Ophthalmology | New York, NY | $2,864 | 18 |
| , M.D | Ophthalmology | Bala Cynwyd, PA | $2,576 | 6 |
| , MD | Ophthalmology | Newport Beach, CA | $2,486 | 1 |
| Inder Singh | Ophthalmology | Racine, WI | $2,376 | 4 |
Ad
Manufacturing Companies
- Alcon Vision LLC $357,341
- Alcon Research Ltd $122,840
- Alcon Laboratories Inc $9,329
- Alcon Research LLC $1,820
Product Information
- Type Drug
- Total Payments $491,329
- Total Doctors 4,848
- Transactions 10,431
About Simbrinza
Simbrinza is a drug associated with $491,329 in payments to 4,848 healthcare providers, recorded across 10,431 transactions in the CMS Open Payments database. The primary manufacturer is Alcon Vision LLC.
Payment data is available from 2017 to 2024. In 2024, $24,942 was paid across 1,366 transactions to 546 doctors.
The most common payment nature for Simbrinza is "Food and Beverage" ($231,512, 47.1% of total).
Simbrinza is associated with 1 research study, including "24-hr Intraocular pressure control with Brinzolamide 1% / Brimonidine 0.2% ophthalmic suspension vs. vehicle." ($122,840).